RxDoctor Payments Data

Susan Criswell, MD

Neurology · Phoenix, AZNPI 1619993938

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $9,392 of the $9,467 with a category attached, or 99.2%. AbbVie accounts for 91.9% of it on its own, with 1 other manufacturer making up the rest.

$9,467in general payments, 2019–2025

Across 13 payments — averaging $728.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$9K
  • Vertex$767
$1,139,488in research payments, 2019–2025

Across 158 payments — averaging $7211.95 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Genentech, Inc.$432K
  • AbbVie$361K
  • Amneal Pharmaceuticals LLC$211K
  • Biogen$101K
  • Eli Lilly$19K
  • Roche TCRC, Inc.$15K

What the payments were for

  • Consulting fees$9,39299%
  • Food & beverage$751%

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)11$8,700
Vertex2$767

How this compares

$9,467 in reported general payments places this provider in the 70th percentile of 388 neurology providers in Arizona.

See all neurology providers in Arizona

Medicare billing

Part B allowed, 2024
$17,900
Medicare patients
58
Services billed
677

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RytaryCarbidopa/Levodopa15$11,148
Carbidopa-LevodopaCarbidopa/Levodopa163$3,839
Carbidopa-Levodopa ErCarbidopa/Levodopa26$1,939
Entacapone14$846
Gabapentin37$440
Ropinirole Hcl13$126
Donepezil Hcl19$104
Pramipexole DihydrochloridePramipexole Di-Hcl11$67
Clonazepam19$49

Paid to pharmacies, not to this prescriber.

Other neurology in Phoenix

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →